|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Genmab (NASDAQ: GMAB) through any online brokerage.
The latest price target for Genmab (NASDAQ: GMAB) was reported by Morgan Stanley on April 19, 2021. The analyst firm set a price target for 37.00 expecting GMAB to fall to within 12 months (a possible -16.18% downside). 17 analyst firms have reported ratings in the last year.
The stock price for Genmab (NASDAQ: GMAB) is $44.14 last updated Mon Jun 14 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Genmab.
There is no upcoming split for Genmab.
Genmab is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.